Moderna @moderna_tx · 19 Aug 2026
Moderna and @Merck today announced positive topline results from the Phase 3 INTerpath-001 trial evaluating adjuvant treatment with intismeran autogene, a novel investigational mRNA-based individualized neoantigen therapy jointly developed by Merck and Moderna, in combination https://t.co/v4DjH0r823
1 758 648Views
7 202Likes
1 434Reposts
0Replies
468Quotes
773Bookmarks
Is that a lot?
19.0×vs this author's median92 367 views is typical
80Percentile for this authorof 5 recent posts
197×vs 100K–1M median8 935 views is typical
12.1× audienceReachviews ÷ followers
0.52%Engagement rateof viewers reacted